Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • AllSeq
    Registered Vendor
    • Oct 2013
    • 138

    The Futility of Defining Sequencing "Generations"

    I just recently answered a question on Quora about the number of “sequencing generations” there are. (My answer was basically that the concept of generations for sequencing has never been used consistently, doesn’t make much sense and isn’t very helpful.) In doing so I quickly categorized the various technologies based on a number of attributes:

    1) sequencing-by-synthesis vs direct sequencing (vs ligation vs hybridization)
    2) stepped vs continuous sequencing
    3) optical vs non-optical detection
    4) short vs long reads
    5) single molecule vs amplified

    And here’s how I mapped the major platforms to these categories:

    Illumina = SBS, stepped, optical, short read, amplified
    Ion = SBS, continuous, non-optical, short read, amplified
    PacBio = SBS, continuous, optical, long read, single molecule
    Oxford Nanopore = direct, continuous, non-optical, long read, single molecule
    Helicos/SeqLL = SBS, stepped, optical, short read, single molecule
    454 = SBS, continuous, optical, short*, amplified (* considered ‘long reads’ at the time, but now at least an order of magnitude shorter than the long read technologies)
    SOLiD = ligation, stepped, optical, short read, amplified

    I’d be curious to hear what others think. The least satisfying is the “stepped vs continuous” category. ONT doesn’t fit perfectly cleanly as they could be considered “stepped” since a ratcheting protein is used, but it doesn’t have the distinct cycles of Illumina’s SBS chemistry. Also, I wasn’t 100% sure about the Helicos technology – is it cycle driven or continuous like Ion? Thoughts?
    AllSeq - The Sequencing Marketplace
    [email protected]
    www.AllSeq.com
  • SNPsaurus
    Registered Vendor
    • May 2013
    • 525

    #2
    Helicos is one base then image, like Illumina.

    I think nanopores are continuous. I don't see much of a difference between a polymerase adding nucs and a template being moved through a pore by enzymatic action. Certainly the timescales involved group Oxford Nanopore with other continuous platforms.

    Nice way to organize them, though!
    Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

    Comment

    • AllSeq
      Registered Vendor
      • Oct 2013
      • 138

      #3
      Originally posted by SNPsaurus View Post
      I don't see much of a difference between a polymerase adding nucs and a template being moved through a pore by enzymatic action.
      That's a really good point!
      AllSeq - The Sequencing Marketplace
      [email protected]
      www.AllSeq.com

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        You missed out sanger sequencing (e.g. ABI 3730), which doesn't really fit into the nice bins you've created. My best guess:

        SBS, stepped, optical, long, amplified

        Are there any electrical (or non-optical) sanger sequencers around? Would radiosequencing count?

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          You should consider a "time to sequence" component.

          We went from day(s) (if you include sub-cloning needed etc) in case of Sanger (first radio-labled then ABI) to less than a week (454, initial Illumina) to back to days (2000,2500), <24h (PacBio per SMRTcell, Ion per chip, not counting prep) and back down to a couple of hours (nanopore).
          Last edited by GenoMax; 01-15-2017, 05:49 AM.

          Comment

          • gringer
            David Eccles (gringer)
            • May 2011
            • 845

            #6
            For pure detection only, nanopore can give you a diagnostic indication within a couple of minutes (assuming a great flow cell, great sample prep, and high proportion of target genome in the sample) -- It doesn't really make sense declaring a particular length of time for sequencing. Maybe 'interruptible' would be better.

            Comment

            • AllSeq
              Registered Vendor
              • Oct 2013
              • 138

              #7
              Originally posted by gringer View Post
              You missed out sanger sequencing (e.g. ABI 3730), which doesn't really fit into the nice bins you've created. My best guess:

              SBS, stepped, optical, long, amplified

              Are there any electrical (or non-optical) sanger sequencers around? Would radiosequencing count?
              I specifically avoided Sanger sequencing, partly out of laziness and partly because people usually refer to 'generations' in 'next generation' sequencing. That said, I would agree with your assessment apart from 'long' - PacBio and ONT have really redefined what 'long reads' mean! Also, I think radiosequencing would still count as 'optical' as film is used as the detection method.
              AllSeq - The Sequencing Marketplace
              [email protected]
              www.AllSeq.com

              Comment

              • AllSeq
                Registered Vendor
                • Oct 2013
                • 138

                #8
                Originally posted by GenoMax View Post
                You should consider a "time to sequence" component.

                We went from day(s) (if you include sub-cloning needed etc) in case of Sanger (first radio-labled then ABI) to less than a week (454, initial Illumina) to back to days (2000,2500), <24h (PacBio per SMRTcell, Ion per chip, not counting prep) and back down to a couple of hours (nanopore).
                Adding "time to sequence" is an interesting idea, but it seems complicated. I was keeping the list at a pretty high level - e.g., Illumina vs PacBio. The time to sequence would vary depending on a specific platform (e.g, MiSeq vs HiSeq X) and would vary from application to application. But it is definitely an important variable.
                AllSeq - The Sequencing Marketplace
                [email protected]
                www.AllSeq.com

                Comment

                Latest Articles

                Collapse

                • mylaser
                  Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by mylaser
                  Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
                  If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
                  This guide explains everything you need to know about...
                  Today, 01:13 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                16 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-08-2026, 10:08 AM
                0 responses
                10 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-07-2026, 11:05 AM
                0 responses
                22 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-02-2026, 11:08 AM
                0 responses
                31 views
                0 reactions
                Last Post SEQadmin2  
                Working...